Imaging identifies breast cancer patients unlikely to benefit from hormone therapy

Hormone therapy can be effective for receptor-positive breast cancer, but it only works for 55% of patients. Researchers at Washington University School of Medicine in St. Louis found that only women whose tumors responded to a one-day estrogen challenge benefited from hormone therapy. The findings could help improve treatment decisions.

Multiomics, Gentational Cd Exposure, Estrogen Receptor Transactivation, and More Featured in December 2020 Toxicological Sciences

The December 2020 issue of the Society of Toxicology’s official journal, Toxicological Sciences, delivers cutting-edge toxicological research in endocrine toxicology, environmental toxicology, organ-specific toxicology, and more.